Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NMDA receptor is an ionotropic glutamate receptor that plays a crucial role in excitatory neurotransmission, synaptic plasticity, learning, and memory. It is a heterotetramer composed of two NR1 (GluN1) subunits and two NR2A (GluN2A) subunits. Activation requires simultaneous binding of glycine/D-serine to NR1 and glutamate to NR2A, leading to the influx of Ca²⁺ and Na⁺ ions and efflux of K⁺ ions. The NR1-NR2A receptor exhibits high calcium permeability, voltage-dependent Mg²⁺ block, and sensitivity to allosteric modulators like Zn²⁺. It is widely expressed in the brain and its function is implicated in various neurological disorders.
Ion channel agonist/antagonist; Allosteric modulation of channel activity
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NMDA Receptor (NR1-NR2A Subunit) (None).